Cite
HARVARD Citation
Behrens, S. et al. (2018). Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care. International psychogeriatrics. pp. 1499-1507. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Behrens, S. et al. (2018). Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care. International psychogeriatrics. pp. 1499-1507. [Online].